Bain-backed startup strikes $500M deal with Eli Lilly

A month after detailing its strategic shift toward autoimmune diseases and cancer, Nimbus Therapeutics has captured the interest of a major pharmaceutical player.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news